Pro Share Advisors LLC Clovis Oncology, Inc. Transaction History

Pro Share Advisors LLC

$39.7 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 04, 2022	BUY	$1.05 - $2.85 $995 - $2,701	948 Added 8.46%	12,153 $14,000
Q2 2022 Aug 01, 2022	SELL	$0.63 - $2.96 $15,554 - $73,082	-24,690 Reduced 68.78%	11,205 $20,000
Q1 2022 May 10, 2022	SELL	$1.43 - $3.14 $10,090 - $22,155	-7,056 Reduced 16.43%	35,895 $73,000
Q4 2021 Feb 08, 2022	BUY	$2.7 - $4.76 $8,637 - $15,227	3,199 Added 8.05%	42,951 $117,000
Q3 2021 Nov 12, 2021	SELL	$4.06 - $5.8 $19,930 - $28,472	-4,909 Reduced 10.99%	39,752 $177,000
Q2 2021 Aug 13, 2021	BUY	$5.02 - $7.05 $39,612 - $55,631	7,891 Added 21.46%	44,661 $259,000
Q1 2021 May 14, 2021	BUY	$4.81 - $10.34 $22,924 - $49,280	4,766 Added 14.89%	36,770 $258,000
Q4 2020 Feb 09, 2021	BUY	$4.13 - $6.41 $90,186 - $139,975	21,837 Added 214.78%	32,004 $154,000
Q3 2020 Nov 13, 2020	BUY	$4.82 - $7.72 $49,004 - $78,489	10,167 New	10,167 $59,000
Q4 2019 Feb 12, 2020	SELL	$3.0 - $16.43 $61,596 - $337,340	-20,532 Closed	0 $0
Q3 2019 Nov 12, 2019	SELL	$3.93 - $15.35 $4,998 - $19,525	-1,272 Reduced 5.83%	20,532 $81,000
Q2 2019 Aug 13, 2019	SELL	$12.81 - $25.67 $44,527 - $89,228	-3,476 Reduced 13.75%	21,804 $324,000
Q1 2019 May 15, 2019	BUY	$17.66 - $30.28 $14,922 - $25,586	845 Added 3.46%	25,280 $627,000
Q4 2018 Feb 14, 2019	SELL	$11.63 - $32.67 $54,870 - $154,137	-4,718 Reduced 16.18%	24,435 $439,000
Q3 2018 Nov 14, 2018	SELL	$29.37 - $49.48 $13,333 - $22,463	-454 Reduced 1.53%	29,153 $856,000
Q2 2018 Aug 13, 2018	SELL	$42.06 - $62.4 $27,212 - $40,372	-647 Reduced 2.14%	29,607 $1.35 Million
Q1 2018 May 14, 2018	SELL	$50.12 - $67.72 $200,279 - $270,609	-3,996 Reduced 11.67%	30,254 $1.6 Million
Q4 2017 Feb 14, 2018	BUY	$57.69 - $84.58 $146,474 - $214,748	2,539 Added 8.01%	34,250 $2.33 Million
Q3 2017 Nov 13, 2017	BUY	$67.17 - $84.81 $330,073 - $416,756	4,914 Added 18.34%	31,711 $2.61 Million
Q2 2017 Aug 11, 2017	BUY	N/A	26,797	26,797 $2.51 Million

Others Institutions Holding CLVS

# of Institutions

Shares Held

166

Call Options Held

Put Options Held

Exane Derivatives

166
Shares

$14
0.0% of portfolio

View Full List

About Clovis Oncology, Inc.

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

More about CLVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Account